Skip to main content

Advertisement

Log in

Intraductal Papillary Mucinous Neoplasms of the Pancreas: Clinicopathologic Characteristics and Long-Term Follow-Up After Resection

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Resection is recommended for main duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas because of the high risk of malignancy, but the indications for resection of branch duct and mixed-type IPMNs remain controversial. Our objective was to determine the appropriate management of IPMNs based on clinicopathologic characteristics and survival data obtained after resection.

Methods

A total of 72 consecutive IPMN patients who underwent resection between January 1984 and June 2006 were reviewed. The lesions were classified as main duct, branch duct, or mixed-type IPMNs and histologically graded as noninvasive (adenoma, borderline neoplasm, carcinoma in situ) or invasive.

Results

Main duct IPMNs (n = 15) were associated with a significantly worse prognosis than other subtypes. For branch duct (n = 49) and mixed-type IPMNs (n = 8), the diameter of the cystic lesions was an independent predictor of malignancy by multivariate analysis. However, four patients with cysts <30 mm in diameter and no mural nodules had a malignancy. No patient with noninvasive IPMN died of this disease, showing excellent survival, whereas the 5-year survival rate of patients with invasive IPMNs was only 57.6% and was significantly worse than that of patients with noninvasive IPMNs (p = 0.0002).

Conclusions

Resection of all main duct IPMNs seems to be reasonable. Invasive IPMNs were associated with significantly worse survival than noninvasive IPMNs. Although the diameter of cystic lesions was a predictor of malignancy for branch duct and mixed-type IPMNs, precise preoperative identification of malignancy was difficult. Therefore, these lesions should be managed by aggressive resection before invasion occurs to improve survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ohashi K, Murakami Y, Maruyama M, et al. (1982) Four cases of “mucin-producing” cancer of the pancreas on specific findings of the papilla of Vater [in Japanese]. Prog Dig Endosc 20:348–351

    Google Scholar 

  2. Kloeppel G, Solcia E, Longnecker DS, et al. (1996) Histological typing of tumours of the exocrine pancreas. in: World Health Organization International Histological Classification of Tumours. 2nd edition. Springer, Berlin

  3. Longnecker DS, Adler G, Hruban RH, et al. (2000) Intraductal papillary mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA (eds) World Health Organization Classification of Tumours, Pathology and Genetics of Tumors of the Digestive System. IARC Press, Lyon, pp 237–241

    Google Scholar 

  4. Tanaka M, Kiishiro K, Kazuhiro M, et al. (2005) Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol 40:669–675

    Article  PubMed  Google Scholar 

  5. Tanaka M, Chari S, Adsay V, et al. (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasm and mucinous cystic neoplasm of the pancreas. Pancreatology 6:17–32

    Article  PubMed  Google Scholar 

  6. Doi R, Fujimoto K, Wada M, et al. (2002) Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery 132:80–85

    Article  PubMed  Google Scholar 

  7. Sohn TA, Yeo CJ, Cameron JL, et al. (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239:788–799

    Article  PubMed  Google Scholar 

  8. Wada K, Kozarek RA, Traverso LW (2005) Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg 189:632–637

    Article  PubMed  Google Scholar 

  9. Matsumoto T, Aramaki M, Yada K, et al. (2003) Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 36:261–265

    Article  PubMed  Google Scholar 

  10. Sugiyama M, Izumisato Y, Abe N, et al. (2003) Predictive factors for malignancy in intraductal papillary mucinous tumours of the pancreas. Br J Surg 90:1244–1249

    Article  PubMed  CAS  Google Scholar 

  11. Salvia R, Fernández-del Castillo C, Bassi C, et al. (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239:678–687

    Article  PubMed  Google Scholar 

  12. Yamaguchi K, Ogawa Y, Chijiiwa K, et al. (1996) Mucin hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively. Am J Surg 171:427–431

    Article  PubMed  CAS  Google Scholar 

  13. Traverso LW, Peralta EA, Ryan JA Jr, et al. (1998) Intraductal neoplasms of the pancreas. Am J Surg 175:426–432

    Article  PubMed  CAS  Google Scholar 

  14. Sugiyama M, Atomi Y (1998) Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg 228:685–691

    Article  PubMed  CAS  Google Scholar 

  15. Shima Y, Mori M, Takakura N, et al. (2000) Diagnosis and management of cystic pancreatic tumours with mucin production. Br J Surg 87:1041–1047

    Article  PubMed  CAS  Google Scholar 

  16. Sobin LH, Wittekind Ch (2002) International Union Against Cancer (UICC): TNM Classification of Malignant Tumours. 6th edition. Wiley-Liss, New York

    Google Scholar 

  17. Inokuma T, Tamaki N, Torizuka T, et al. (1995) Eevaluation of pancreatic tumors with positron emission tomography and 18F-fluorodeoxyglucose: comparison with CT and US. Radiology 195:345–352

    PubMed  CAS  Google Scholar 

  18. Suzuki Y, Atomi Y, Sugiyama M, et al. (2004) Cystic neoplasms of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 28:241–246

    Article  PubMed  Google Scholar 

  19. Yamao K, Ohashi K, Nakamura T, et al. (2001) Evaluation of various imaging methods in the differential diagnosis of intraductal papillary mucinous tumor (IPMT) of the pancreas. Hepatogastroenterology 48:962–966

    PubMed  CAS  Google Scholar 

  20. Sosa JA, Bowman HM, Gordon TA, et al. (1998) Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 228:429–438

    Article  PubMed  CAS  Google Scholar 

  21. Gouma DJ, van Geenen RC, van Gulik TM, et al. (2000) Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 232:786–795

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Grants-in-Aid (17390364, 17659409) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ryuichiro Doi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagai, K., Doi, R., Kida, A. et al. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Clinicopathologic Characteristics and Long-Term Follow-Up After Resection. World J Surg 32, 271–278 (2008). https://doi.org/10.1007/s00268-007-9281-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-007-9281-2

Keywords

Navigation